Sign up for The A.V. Club's free newsletter to have the best TV, film, and news stories sent straight to your inbox. If there’s one thing John Oliver does better ...

Cheap labor and global supply chains are among the obstacles to President Trump’s plan to bring generic drug manufacturing back home. Credit...Video by Harsha Vadlamani Supported by By Alex Travelli ...

Illinois residents who purchased a generic drug between May 2009 and December 2019 could be eligible for payouts as part of a series of allegations that drug companies conspired to manipulate prices.

Viatris' Mylan Pharmaceuticals asked the court, opens new tab in a filing made public on Thursday to find that its generic would not infringe Novo's patent ⁠covering a method of administering ...

Did you pay for a generic prescription drug between May 2009 and December 2019? If so, you may be eligible to receive money from settlements involving some generic drug manufacturers. The Pennsylvania ...

Sandoz Group SDZ2.55%increase; up pointing triangle said it received approval from Canada’s drug regulator for its generic version of Novo Nordisk’s NOVO.B-1.46%decrease; down pointing triangle ...

Sandoz CEO Richard Saynor warned U.S. patients could ultimately bear the cost of threatened tariffs on imported generic drugs. Saynor said manufacturers facing steep tariffs could be forced to raise ...